NOP2_HUMAN - dbPTM
NOP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NOP2_HUMAN
UniProt AC P46087
Protein Name Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase
Gene Name NOP2
Organism Homo sapiens (Human).
Sequence Length 812
Subcellular Localization Nucleus, nucleolus .
Protein Description Involved in ribosomal large subunit assembly. [PubMed: 24120868 S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the C(5) position of cytosine 4447 in 28S rRNA (Probable May play a role in the regulation of the cell cycle and the increased nucleolar activity that is associated with the cell proliferation (Probable]
Protein Sequence MGRKLDPTKEKRGPGRKARKQKGAETELVRFLPAVSDENSKRLSSRARKRAAKRRLGSVEAPKTNKSPEAKPLPGKLPKGISAGAVQTAGKKGPQSLFNAPRGKKRPAPGSDEEEEEEDSEEDGMVNHGDLWGSEDDADTVDDYGADSNSEDEEEGEALLPIERAARKQKAREAAAGIQWSEEETEDEEEEKEVTPESGPPKVEEADGGLQINVDEEPFVLPPAGEMEQDAQAPDLQRVHKRIQDIVGILRDFGAQREEGRSRSEYLNRLKKDLAIYYSYGDFLLGKLMDLFPLSELVEFLEANEVPRPVTLRTNTLKTRRRDLAQALINRGVNLDPLGKWSKTGLVVYDSSVPIGATPEYLAGHYMLQGASSMLPVMALAPQEHERILDMCCAPGGKTSYMAQLMKNTGVILANDANAERLKSVVGNLHRLGVTNTIISHYDGRQFPKVVGGFDRVLLDAPCSGTGVISKDPAVKTNKDEKDILRCAHLQKELLLSAIDSVNATSKTGGYLVYCTCSITVEENEWVVDYALKKRNVRLVPTGLDFGQEGFTRFRERRFHPSLRSTRRFYPHTHNMDGFFIAKFKKFSNSIPQSQTGNSETATPTNVDLPQVIPKSENSSQPAKKAKGAAKTKQQLQKQQHPKKASFQKLNGISKGADSELSTVPSVTKTQASSSFQDSSQPAGKAEGIREPKVTGKLKQRSPKLQSSKKVAFLRQNAPPKGTDTQTPAVLSPSKTQATLKPKDHHQPLGRAKGVEKQQLPEQPFEKAAFQKQNDTPKGPQPPTVSPIRSSRPPPAKRKKSQSRGNSQLLLS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Ubiquitination----MGRKLDPTKEK
----CCCCCCCCCCC
52.0624816145
22MethylationGRKARKQKGAETELV
CHHHHHHCCCCHHHH
64.22116252317
22UbiquitinationGRKARKQKGAETELV
CHHHHHHCCCCHHHH
64.2233845483
36PhosphorylationVRFLPAVSDENSKRL
HHHHHHCCCHHHHHH
41.1125159151
36 (in isoform 2)Phosphorylation-41.11-
40PhosphorylationPAVSDENSKRLSSRA
HHCCCHHHHHHHHHH
19.6628464451
41AcetylationAVSDENSKRLSSRAR
HCCCHHHHHHHHHHH
69.7825953088
41UbiquitinationAVSDENSKRLSSRAR
HCCCHHHHHHHHHHH
69.7833845483
44PhosphorylationDENSKRLSSRARKRA
CHHHHHHHHHHHHHH
23.0828464451
45PhosphorylationENSKRLSSRARKRAA
HHHHHHHHHHHHHHH
34.2524719451
45 (in isoform 2)Phosphorylation-34.2524719451
58PhosphorylationAAKRRLGSVEAPKTN
HHHHHHCCCCCCCCC
22.7529255136
58 (in isoform 2)Phosphorylation-22.7524719451
58 (in isoform 4)Phosphorylation-22.7527251275
64PhosphorylationGSVEAPKTNKSPEAK
CCCCCCCCCCCCCCC
46.9823927012
64 (in isoform 2)Phosphorylation-46.98-
67PhosphorylationEAPKTNKSPEAKPLP
CCCCCCCCCCCCCCC
30.0029255136
67 (in isoform 2)Phosphorylation-30.0029743597
67 (in isoform 3)Phosphorylation-30.0029743597
67 (in isoform 4)Phosphorylation-30.0027251275
71SumoylationTNKSPEAKPLPGKLP
CCCCCCCCCCCCCCC
45.48-
71AcetylationTNKSPEAKPLPGKLP
CCCCCCCCCCCCCCC
45.4825953088
71SumoylationTNKSPEAKPLPGKLP
CCCCCCCCCCCCCCC
45.4828112733
76AcetylationEAKPLPGKLPKGISA
CCCCCCCCCCCCCCC
60.7325953088
76UbiquitinationEAKPLPGKLPKGISA
CCCCCCCCCCCCCCC
60.7333845483
79AcetylationPLPGKLPKGISAGAV
CCCCCCCCCCCCCCC
78.3519816785
82PhosphorylationGKLPKGISAGAVQTA
CCCCCCCCCCCCCCC
29.3525159151
88PhosphorylationISAGAVQTAGKKGPQ
CCCCCCCCCCCCCCH
30.6825159151
91AcetylationGAVQTAGKKGPQSLF
CCCCCCCCCCCHHHH
52.6825953088
92AcetylationAVQTAGKKGPQSLFN
CCCCCCCCCCHHHHC
74.9426051181
96PhosphorylationAGKKGPQSLFNAPRG
CCCCCCHHHHCCCCC
37.7525159151
96 (in isoform 4)Phosphorylation-37.7527251275
102CitrullinationQSLFNAPRGKKRPAP
HHHHCCCCCCCCCCC
68.12-
102CitrullinationQSLFNAPRGKKRPAP
HHHHCCCCCCCCCCC
68.12-
107 (in isoform 2)Phosphorylation-52.25-
111PhosphorylationKKRPAPGSDEEEEEE
CCCCCCCCCHHHHHH
40.5727362937
116 (in isoform 2)Phosphorylation-70.71-
120PhosphorylationEEEEEEDSEEDGMVN
HHHHHHHCCCCCCCC
46.2827362937
130 (in isoform 2)Phosphorylation-31.53-
134PhosphorylationNHGDLWGSEDDADTV
CCHHCCCCCCCCCCC
26.6922817900
136 (in isoform 2)Phosphorylation-59.08-
140PhosphorylationGSEDDADTVDDYGAD
CCCCCCCCCCCCCCC
27.7922817900
146 (in isoform 2)Phosphorylation-15.72-
148PhosphorylationVDDYGADSNSEDEEE
CCCCCCCCCCCCHHH
41.5427362937
150PhosphorylationDYGADSNSEDEEEGE
CCCCCCCCCCHHHHH
50.8327362937
164CitrullinationEALLPIERAARKQKA
HHHHHHHHHHHHHHH
33.98-
164CitrullinationEALLPIERAARKQKA
HHHHHHHHHHHHHHH
33.98-
177 (in isoform 2)Phosphorylation-14.1124719451
180 (in isoform 4)Phosphorylation-13.0422468782
181PhosphorylationAAAGIQWSEEETEDE
HHHCCCCCHHHCCCH
20.8222167270
181 (in isoform 2)Phosphorylation-20.8224719451
183 (in isoform 4)Phosphorylation-65.7822468782
185PhosphorylationIQWSEEETEDEEEEK
CCCCHHHCCCHHHHC
52.6022167270
187 (in isoform 4)Phosphorylation-75.8422468782
191 (in isoform 2)Phosphorylation-58.77-
194 (in isoform 2)Phosphorylation-18.75-
195PhosphorylationEEEEKEVTPESGPPK
HHHHCCCCCCCCCCC
23.5629255136
198PhosphorylationEKEVTPESGPPKVEE
HCCCCCCCCCCCCEE
58.7830266825
214 (in isoform 4)Phosphorylation-11.9327251275
218 (in isoform 4)Phosphorylation-23.6927251275
228 (in isoform 4)Phosphorylation-40.7927251275
258 (in isoform 2)Phosphorylation-53.36-
262PhosphorylationAQREEGRSRSEYLNR
CCCHHCCCHHHHHHH
51.5219691289
264PhosphorylationREEGRSRSEYLNRLK
CHHCCCHHHHHHHHH
31.6619691289
266PhosphorylationEGRSRSEYLNRLKKD
HCCCHHHHHHHHHHH
15.5526270265
272SumoylationEYLNRLKKDLAIYYS
HHHHHHHHHHHHEEH
63.6728112733
336UbiquitinationINRGVNLDPLGKWSK
HHCCCCCCCCCCCCC
31.0421890473
336 (in isoform 2)Ubiquitination-31.0421890473
336UbiquitinationINRGVNLDPLGKWSK
HHCCCCCCCCCCCCC
31.0421890473
339UbiquitinationGVNLDPLGKWSKTGL
CCCCCCCCCCCCCCE
34.4722817900
340AcetylationVNLDPLGKWSKTGLV
CCCCCCCCCCCCCEE
56.8525953088
340UbiquitinationVNLDPLGKWSKTGLV
CCCCCCCCCCCCCEE
56.8522817900
343UbiquitinationDPLGKWSKTGLVVYD
CCCCCCCCCCEEEEC
45.5622817900
344PhosphorylationPLGKWSKTGLVVYDS
CCCCCCCCCEEEECC
30.1724043423
349PhosphorylationSKTGLVVYDSSVPIG
CCCCEEEECCCCCCC
11.5724043423
351PhosphorylationTGLVVYDSSVPIGAT
CCEEEECCCCCCCCC
18.6224043423
352PhosphorylationGLVVYDSSVPIGATP
CEEEECCCCCCCCCH
29.0824043423
358PhosphorylationSSVPIGATPEYLAGH
CCCCCCCCHHHHCHH
16.0724043423
361PhosphorylationPIGATPEYLAGHYML
CCCCCHHHHCHHHHH
11.7626074081
366PhosphorylationPEYLAGHYMLQGASS
HHHHCHHHHHCCHHH
9.9026074081
372PhosphorylationHYMLQGASSMLPVMA
HHHHCCHHHHCCHHH
24.0926074081
373PhosphorylationYMLQGASSMLPVMAL
HHHCCHHHHCCHHHH
24.6526074081
373UbiquitinationYMLQGASSMLPVMAL
HHHCCHHHHCCHHHH
24.6521890473
373 (in isoform 1)Ubiquitination-24.6521890473
373UbiquitinationYMLQGASSMLPVMAL
HHHCCHHHHCCHHHH
24.6521890473
376UbiquitinationQGASSMLPVMALAPQ
CCHHHHCCHHHHCCC
12.7522817900
398UbiquitinationMCCAPGGKTSYMAQL
HHCCCCCHHHHHHHH
39.97-
403UbiquitinationGGKTSYMAQLMKNTG
CCHHHHHHHHHHHCC
7.3621963094
407AcetylationSYMAQLMKNTGVILA
HHHHHHHHHCCEEEE
61.0126051181
407UbiquitinationSYMAQLMKNTGVILA
HHHHHHHHHCCEEEE
61.0121963094
419UbiquitinationILANDANAERLKSVV
EEECCCCHHHHHHHH
12.6629967540
423AcetylationDANAERLKSVVGNLH
CCCHHHHHHHHHHHH
47.6425953088
423UbiquitinationDANAERLKSVVGNLH
CCCHHHHHHHHHHHH
47.6429967540
440UbiquitinationGVTNTIISHYDGRQF
CCCCEEEECCCCCCC
16.4921963094
442PhosphorylationTNTIISHYDGRQFPK
CCEEEECCCCCCCCC
17.1925839225
445UbiquitinationIISHYDGRQFPKVVG
EEECCCCCCCCCEEC
31.8829967540
449UbiquitinationYDGRQFPKVVGGFDR
CCCCCCCCEECCCCE
51.3329967540
456UbiquitinationKVVGGFDRVLLDAPC
CEECCCCEEEEECCC
20.7929967540
467UbiquitinationDAPCSGTGVISKDPA
ECCCCCCCCCCCCCC
20.4921963094
471AcetylationSGTGVISKDPAVKTN
CCCCCCCCCCCCCCC
57.5226051181
471UbiquitinationSGTGVISKDPAVKTN
CCCCCCCCCCCCCCC
57.5221963094
472UbiquitinationGTGVISKDPAVKTNK
CCCCCCCCCCCCCCC
29.6033845483
476UbiquitinationISKDPAVKTNKDEKD
CCCCCCCCCCCCHHH
48.7833845483
479AcetylationDPAVKTNKDEKDILR
CCCCCCCCCHHHHHH
72.9326051181
482AcetylationVKTNKDEKDILRCAH
CCCCCCHHHHHHHHH
61.2723749302
482UbiquitinationVKTNKDEKDILRCAH
CCCCCCHHHHHHHHH
61.2729967540
488UbiquitinationEKDILRCAHLQKELL
HHHHHHHHHHHHHHH
10.4529967540
492AcetylationLRCAHLQKELLLSAI
HHHHHHHHHHHHHHH
57.6025953088
492UbiquitinationLRCAHLQKELLLSAI
HHHHHHHHHHHHHHH
57.6029967540
497PhosphorylationLQKELLLSAIDSVNA
HHHHHHHHHHHHCCC
24.1321601212
501PhosphorylationLLLSAIDSVNATSKT
HHHHHHHHCCCCCCC
15.9120068231
501 (in isoform 2)Phosphorylation-15.91-
502 (in isoform 2)Phosphorylation-5.11-
504UbiquitinationSAIDSVNATSKTGGY
HHHHHCCCCCCCCCE
15.8721963094
505PhosphorylationAIDSVNATSKTGGYL
HHHHCCCCCCCCCEE
26.0820068231
506PhosphorylationIDSVNATSKTGGYLV
HHHCCCCCCCCCEEE
26.3020068231
509UbiquitinationVNATSKTGGYLVYCT
CCCCCCCCCEEEEEE
26.8733845483
525UbiquitinationSITVEENEWVVDYAL
EEEEECCCEEEEEHH
44.9529967540
562PhosphorylationRERRFHPSLRSTRRF
HHHCCCCCHHCCCCC
28.0424719451
573O-linked_GlycosylationTRRFYPHTHNMDGFF
CCCCCCCCCCCCCEE
15.5031373491
588PhosphorylationIAKFKKFSNSIPQSQ
EEEHHHHHCCCCHHH
38.2522199227
590PhosphorylationKFKKFSNSIPQSQTG
EHHHHHCCCCHHHCC
34.1521815630
592 (in isoform 2)Phosphorylation-27.82-
594PhosphorylationFSNSIPQSQTGNSET
HHCCCCHHHCCCCCC
25.1025850435
596PhosphorylationNSIPQSQTGNSETAT
CCCCHHHCCCCCCCC
43.5125159151
599PhosphorylationPQSQTGNSETATPTN
CHHHCCCCCCCCCCC
37.3526657352
599 (in isoform 2)Phosphorylation-37.3524719451
601PhosphorylationSQTGNSETATPTNVD
HHCCCCCCCCCCCCC
35.3325850435
603PhosphorylationTGNSETATPTNVDLP
CCCCCCCCCCCCCCC
37.7625159151
605PhosphorylationNSETATPTNVDLPQV
CCCCCCCCCCCCCCC
43.4430576142
615SumoylationDLPQVIPKSENSSQP
CCCCCCCCCCCCCHH
60.3128112733
616PhosphorylationLPQVIPKSENSSQPA
CCCCCCCCCCCCHHH
36.33-
619PhosphorylationVIPKSENSSQPAKKA
CCCCCCCCCHHHHHH
26.71-
620PhosphorylationIPKSENSSQPAKKAK
CCCCCCCCHHHHHHH
52.33-
627 (in isoform 4)Phosphorylation-58.9427251275
649AcetylationPKKASFQKLNGISKG
CCHHHHHHHCCCCCC
41.7419608861
654PhosphorylationFQKLNGISKGADSEL
HHHHCCCCCCCCCCC
26.8321601212
655AcetylationQKLNGISKGADSELS
HHHCCCCCCCCCCCC
57.0826051181
659PhosphorylationGISKGADSELSTVPS
CCCCCCCCCCCCCCC
39.6428555341
662PhosphorylationKGADSELSTVPSVTK
CCCCCCCCCCCCCCC
24.2529255136
662 (in isoform 2)Phosphorylation-24.25-
663PhosphorylationGADSELSTVPSVTKT
CCCCCCCCCCCCCCC
49.4030266825
666PhosphorylationSELSTVPSVTKTQAS
CCCCCCCCCCCCCCC
37.7730266825
668O-linked_GlycosylationLSTVPSVTKTQASSS
CCCCCCCCCCCCCCC
32.4831373491
668PhosphorylationLSTVPSVTKTQASSS
CCCCCCCCCCCCCCC
32.4830266825
669AcetylationSTVPSVTKTQASSSF
CCCCCCCCCCCCCCC
36.1625953088
670PhosphorylationTVPSVTKTQASSSFQ
CCCCCCCCCCCCCCC
21.7224732914
670 (in isoform 2)Phosphorylation-21.7224719451
671 (in isoform 2)Phosphorylation-40.58-
673PhosphorylationSVTKTQASSSFQDSS
CCCCCCCCCCCCCCC
19.3919691289
674PhosphorylationVTKTQASSSFQDSSQ
CCCCCCCCCCCCCCC
37.8825159151
675PhosphorylationTKTQASSSFQDSSQP
CCCCCCCCCCCCCCC
25.1625159151
679PhosphorylationASSSFQDSSQPAGKA
CCCCCCCCCCCCCCC
21.7924732914
680PhosphorylationSSSFQDSSQPAGKAE
CCCCCCCCCCCCCCC
48.7724732914
681NeddylationSSFQDSSQPAGKAEG
CCCCCCCCCCCCCCC
35.5032015554
681UbiquitinationSSFQDSSQPAGKAEG
CCCCCCCCCCCCCCC
35.5032015554
685AcetylationDSSQPAGKAEGIREP
CCCCCCCCCCCCCCC
45.4226051181
685NeddylationDSSQPAGKAEGIREP
CCCCCCCCCCCCCCC
45.4232015554
685UbiquitinationDSSQPAGKAEGIREP
CCCCCCCCCCCCCCC
45.4232015554
695UbiquitinationGIREPKVTGKLKQRS
CCCCCCCCCCCCCCC
34.4224816145
698 (in isoform 2)Phosphorylation-6.3824719451
699UbiquitinationPKVTGKLKQRSPKLQ
CCCCCCCCCCCCCCC
47.3424816145
702PhosphorylationTGKLKQRSPKLQSSK
CCCCCCCCCCCCCCC
24.7220860994
704AcetylationKLKQRSPKLQSSKKV
CCCCCCCCCCCCCCH
61.4825953088
707PhosphorylationQRSPKLQSSKKVAFL
CCCCCCCCCCCHHHH
55.3423909892
708PhosphorylationRSPKLQSSKKVAFLR
CCCCCCCCCCHHHHH
24.4323909892
709AcetylationSPKLQSSKKVAFLRQ
CCCCCCCCCHHHHHC
57.4226051181
710AcetylationPKLQSSKKVAFLRQN
CCCCCCCCHHHHHCC
40.5226051181
717UbiquitinationKVAFLRQNAPPKGTD
CHHHHHCCCCCCCCC
48.2424816145
718NeddylationVAFLRQNAPPKGTDT
HHHHHCCCCCCCCCC
17.2732015554
718UbiquitinationVAFLRQNAPPKGTDT
HHHHHCCCCCCCCCC
17.2732015554
719 (in isoform 2)Phosphorylation-38.39-
721UbiquitinationLRQNAPPKGTDTQTP
HHCCCCCCCCCCCCC
73.6824816145
723PhosphorylationQNAPPKGTDTQTPAV
CCCCCCCCCCCCCCC
41.8423927012
723 (in isoform 2)Phosphorylation-41.84-
725PhosphorylationAPPKGTDTQTPAVLS
CCCCCCCCCCCCCCC
33.8923927012
727PhosphorylationPKGTDTQTPAVLSPS
CCCCCCCCCCCCCCC
18.4630266825
728PhosphorylationKGTDTQTPAVLSPSK
CCCCCCCCCCCCCCC
15.5632142685
728 (in isoform 2)Phosphorylation-15.5624719451
730 (in isoform 2)Phosphorylation-5.99-
732PhosphorylationTQTPAVLSPSKTQAT
CCCCCCCCCCCCCCC
22.1119664994
732UbiquitinationTQTPAVLSPSKTQAT
CCCCCCCCCCCCCCC
22.1124816145
734PhosphorylationTPAVLSPSKTQATLK
CCCCCCCCCCCCCCC
44.9829255136
735 (in isoform 2)Phosphorylation-48.30-
736PhosphorylationAVLSPSKTQATLKPK
CCCCCCCCCCCCCCC
27.9822167270
739PhosphorylationSPSKTQATLKPKDHH
CCCCCCCCCCCCCCC
26.0422167270
741AcetylationSKTQATLKPKDHHQP
CCCCCCCCCCCCCCC
45.7426051181
753AcetylationHQPLGRAKGVEKQQL
CCCCCCCCCCCHHCC
63.2325953088
754UbiquitinationQPLGRAKGVEKQQLP
CCCCCCCCCCHHCCC
31.6524816145
757AcetylationGRAKGVEKQQLPEQP
CCCCCCCHHCCCCCH
40.7225953088
763UbiquitinationEKQQLPEQPFEKAAF
CHHCCCCCHHHHHHH
46.1533845483
765PhosphorylationQQLPEQPFEKAAFQK
HCCCCCHHHHHHHHH
17.5632142685
765 (in isoform 4)Phosphorylation-17.5627251275
767AcetylationLPEQPFEKAAFQKQN
CCCCHHHHHHHHHCC
45.4525953088
767UbiquitinationLPEQPFEKAAFQKQN
CCCCHHHHHHHHHCC
45.4533845483
772AcetylationFEKAAFQKQNDTPKG
HHHHHHHHCCCCCCC
44.6126051181
772 (in isoform 2)Phosphorylation-44.6124719451
774UbiquitinationKAAFQKQNDTPKGPQ
HHHHHHCCCCCCCCC
63.2624816145
776PhosphorylationAFQKQNDTPKGPQPP
HHHHCCCCCCCCCCC
34.1523927012
778UbiquitinationQKQNDTPKGPQPPTV
HHCCCCCCCCCCCCC
82.4324816145
780 (in isoform 2)Phosphorylation-50.0224719451
782PhosphorylationDTPKGPQPPTVSPIR
CCCCCCCCCCCCCCC
29.6632142685
782 (in isoform 2)Phosphorylation-29.6624719451
784PhosphorylationPKGPQPPTVSPIRSS
CCCCCCCCCCCCCCC
40.0629255136
786PhosphorylationGPQPPTVSPIRSSRP
CCCCCCCCCCCCCCC
19.6529255136
790PhosphorylationPTVSPIRSSRPPPAK
CCCCCCCCCCCCCCC
31.2725159151
791PhosphorylationTVSPIRSSRPPPAKR
CCCCCCCCCCCCCCC
38.6726074081
797 (in isoform 2)Phosphorylation-71.21-
800UbiquitinationPPPAKRKKSQSRGNS
CCCCCCCCCCCCCCC
58.7333845483
801PhosphorylationPPAKRKKSQSRGNSQ
CCCCCCCCCCCCCCC
36.1025159151
803PhosphorylationAKRKKSQSRGNSQLL
CCCCCCCCCCCCCCC
49.6130576142
804MethylationKRKKSQSRGNSQLLL
CCCCCCCCCCCCCCC
40.45115385645
807PhosphorylationKSQSRGNSQLLLS--
CCCCCCCCCCCCC--
25.6525159151
808 (in isoform 2)Phosphorylation-39.8824719451
811UbiquitinationRGNSQLLLS------
CCCCCCCCC------
8.5224816145
812PhosphorylationGNSQLLLS-------
CCCCCCCC-------
37.8430266825
817 (in isoform 4)Phosphorylation-27251275
819PhosphorylationS--------------
C--------------
32142685
845 (in isoform 4)Phosphorylation-27251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NOP2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NOP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NOP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MCRS1_HUMANMCRS1physical
9654073
FBRL_HUMANFBLphysical
9654073
NOP56_HUMANNOP56physical
22939629
RL5_HUMANRPL5physical
22939629
RL11_HUMANRPL11physical
22939629
RL4_HUMANRPL4physical
22939629
RL19_HUMANRPL19physical
22939629
RL23_HUMANRPL23physical
22939629
SPB1_HUMANFTSJ3physical
22939629
RS6_HUMANRPS6physical
22939629
RL6_HUMANRPL6physical
22939629
RL18_HUMANRPL18physical
22939629
RL18A_HUMANRPL18Aphysical
22939629
RRS1_HUMANRRS1physical
22939629
RL15_HUMANRPL15physical
22939629
RS7_HUMANRPS7physical
22939629
RL7_HUMANRPL7physical
22939629
RS8_HUMANRPS8physical
22939629
RS15A_HUMANRPS15Aphysical
22939629
NOP58_HUMANNOP58physical
22939629
RS4X_HUMANRPS4Xphysical
22939629
RL1D1_HUMANRSL1D1physical
22939629
RS2_HUMANRPS2physical
22939629
RL23A_HUMANRPL23Aphysical
22939629
RL30_HUMANRPL30physical
22939629
RS5_HUMANRPS5physical
22939629
SSRP1_HUMANSSRP1physical
22939629
VPS52_HUMANVPS52physical
25416956
IMA7_HUMANKPNA6physical
25416956
CDA7L_HUMANCDCA7Lphysical
25416956
CEP70_HUMANCEP70physical
25416956
BRX1_HUMANBRIX1physical
26344197
CSK22_HUMANCSNK2A2physical
26344197
DDX47_HUMANDDX47physical
26344197
DKC1_HUMANDKC1physical
26344197
EBP2_HUMANEBNA1BP2physical
26344197
PUM3_HUMANKIAA0020physical
26344197
MINK1_HUMANMINK1physical
26344197
MPP10_HUMANMPHOSPH10physical
26344197
MK67I_HUMANNIFKphysical
26344197
NOC2L_HUMANNOC2Lphysical
26344197
NOC3L_HUMANNOC3Lphysical
26344197
NOL6_HUMANNOL6physical
26344197
NOLC1_HUMANNOLC1physical
26344197
NSA2_HUMANNSA2physical
26344197
PRP8_HUMANPRPF8physical
26344197
RPF2_HUMANRPF2physical
26344197
SRSF3_HUMANSRSF3physical
26344197
TOP1_HUMANTOP1physical
26344197
TOP2A_HUMANTOP2Aphysical
26344197
UT14A_HUMANUTP14Aphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NOP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-649, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; THR-185 ANDSER-732, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-58; SER-67;SER-181; THR-185; SER-666; SER-675; SER-732; THR-739; THR-776; SER-786AND SER-812, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-67; SER-181;THR-185; SER-732 AND SER-786, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-786, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-732 AND SER-786,AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; THR-64; SER-67;THR-195; SER-675; SER-732 AND SER-786, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-732, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67 AND SER-734, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; THR-603 ANDSER-732, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-732, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-111; SER-120;SER-134; THR-140; SER-150; SER-181; THR-185 AND SER-732, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-195, AND MASSSPECTROMETRY.

TOP